Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NATIONAL HEALTHCARE CORPNHC · Entity 355 | Director | May 06, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NATIONAL HEALTHCARE CORP
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Shares of Common StockSEC Table I · non-derivative | Direct | 10,640 |
Reported balance
After 2026-05-06 transaction · row 1
1 source rowRow 1 · 2026-05-06 · Exercise / conversion · Acquired 3,140 · Balance 10,640 F1: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 4, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |
| Option to Purchase Common Stock [2023 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $55.75 · Expires 2028-05-03 | Direct | 4,360 |
Reported balance
After 2026-05-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-06 · Exercise / conversion · Disposed 3,140 · Balance 4,360 F1: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 4, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |
| Option to Purchase Common Stock [2024 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $96.03 · Expires 2029-05-08 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-05-06 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 7,500 |
| Option to Purchase Common Stock [2025 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $94.66 · Expires 2030-05-07 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-05-06 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 7,500 |
| Option to Purchase Common Stock [2026 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $171.42 · Expires 2031-05-06 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-05-06 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 7,500 |
Filing footnotes · ownership attribution and instrument terms
F1: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 4, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 07, 2026 Filed May 7, 2026 22:10 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2026 Grant] · Derivative | 7,500 | $0.00 Strike: $171.42 | $0.00 |
DisclosureSEC source: 0001437749-26-015702 · rdgdoc.xml · derivative · entry 5 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2031-05-06 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 06, 2026 Filed May 8, 2026 20:12 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2023 Grant] · Derivative | 3,140 | $0.00 Strike: $55.75 | $0.00 |
DisclosureSEC source: 0001437749-26-015905 · rdgdoc.xml · derivative · entry 2 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,360 Underlying: Common Stock · 7,500 shares Expires 2028-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 4, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 06, 2026 Filed May 8, 2026 20:12 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 3,140 | $55.75 | $175,055.00 |
DisclosureSEC source: 0001437749-26-015905 · rdgdoc.xml · nonDerivative · entry 1 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 4, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 08, 2025 Filed May 9, 2025 20:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2025 Grant] · Derivative | 7,500 | $0.00 Strike: $94.66 | $0.00 |
DisclosureSEC source: 0001437749-25-015793 · rdgdoc.xml · derivative · entry 4 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2030-05-07 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 8, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:50 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2022 Grant] · Derivative | 1,886 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-25-005247 · rdgdoc.xml · derivative · entry 2 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,886 shares Expires 2027-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:50 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 1,886 | $69.19 | $130,492.34 |
DisclosureSEC source: 0001437749-25-005247 · rdgdoc.xml · nonDerivative · entry 1 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| December 02, 2024 Filed Dec 2, 2024 22:34 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2022 Grant] · Derivative | 2,000 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-24-036490 · rdgdoc.xml · derivative · entry 2 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,886 Underlying: Common Stock · 3,886 shares Expires 2027-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| December 02, 2024 Filed Dec 2, 2024 22:34 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 2,000 | $69.19 | $138,380.00 |
DisclosureSEC source: 0001437749-24-036490 · rdgdoc.xml · nonDerivative · entry 1 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 09, 2024 Filed May 13, 2024 21:29 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2024 Grant] · Derivative | 7,500 | $0.00 Strike: $96.03 | $0.00 |
DisclosureSEC source: 0001437749-24-016307 · rdgdoc.xml · derivative · entry 4 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-05-08 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 9, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| August 11, 2023 Filed Aug 14, 2023 20:52 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2022 Grant] · Derivative | 1,807 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-23-023743 · rdgdoc.xml · derivative · entry 2 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,886 Underlying: Common Stock · 5,693 shares Expires 2027-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| August 11, 2023 Filed Aug 14, 2023 20:52 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 1,807 | $69.19 | $125,026.33 |
DisclosureSEC source: 0001437749-23-023743 · rdgdoc.xml · nonDerivative · entry 1 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 04, 2023 Filed May 4, 2023 22:12 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2023 Grant] · Derivative | 7,500 | $0.00 Strike: $55.75 | $0.00 |
DisclosureSEC source: 0001437749-23-012620 · rdgdoc.xml · derivative · entry 3 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2028-05-03 F1 · shares: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 4, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 19:07 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2022 Grant] · Derivative | 1,807 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-22-029129 · rdgdoc.xml · derivative · entry 2 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,690 Underlying: Common Stock · 7,500 shares Expires 2027-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 19:07 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 1,807 | $69.19 | $125,026.33 |
DisclosureSEC source: 0001437749-22-029129 · rdgdoc.xml · nonDerivative · entry 1 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| December 13, 2022 Filed Jan 12, 2023 21:28 UTC Amendment | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2022 Grant] · Derivative | 1,807 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-23-000963 · rdgdoc.xml · derivative · entry 2 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,693 Underlying: Common Stock · 7,500 shares Expires 2027-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Number of shares owned following transaction has been updated here to correct a mathematical error on the original form. Read SEC document |
| December 13, 2022 Filed Jan 12, 2023 21:28 UTC Amendment | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 1,807 | $69.19 | $125,026.33 |
DisclosureSEC source: 0001437749-23-000963 · rdgdoc.xml · nonDerivative · entry 1 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 05, 2022 Filed May 6, 2022 17:57 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2022 Grant] · Derivative | 7,500 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-22-011295 · rdgdoc.xml · derivative · entry 2 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-05-04 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.